Game On: Topokine Initiates Late-Stage Trial of XAF5 Ointment for Reining in Undereye Bags
Topokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
Topokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
Health Canada's licensing of the PicoPretty Q-Switched ND:YAG Laser expands Canadian providers' access to a multi-mode platform for tattoo removal, pigmentation treatment, skin rejuvenation, vascular applications, and hair reduction.
The device uses 2.45-GHz energy and three handpieces designed to target subcutaneous tissue while maintaining surface cooling, according to the company.
The agreement provides Vizient’s network of healthcare providers with enhanced access to the Allergan Aesthetics breast implant line.
Findings provide insight into the biological mechanisms of picosecond lasers for pigmentation disorders and skin aging, potentially enabling safer parameter selection and clinical application.
The device connects to standard operating room suction and is designed to support faster, more controlled explantation without requiring additional capital equipment or specialized training.